Q3 2022 Holdings
Filed 2022-11-14 | 47 holdings | $40.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aadi Biosciences Inc(WHWK) | COM | 00032Q104 | $26.1M | 1,849,402 | 64.0% |
| Celldex Therapeutics Inc(CLDX) | COM NEW | 15117B202 | $7.5M | 267,195 | 18.4% |
| Arrowhead Pharmaceuticals Inc(ARWR) | COM | 04280A100 | $2.9M | 87,500 | 7.1% |
| Aclaris Therapeu(ACRS) | COM | 00461U105 | $2.5M | 160,835 | 6.2% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $1.6M | 125,000 | 3.9% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $37.8K | 554,000 | 0.1% |
| Bellus Health Inc(BLU) | COM NEW | 07987C204 | $15.2K | 1,438,500 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $13.5K | 365,618 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $10.1K | 563,607 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $9.8K | 272,500 | 0.0% |
| Bcls Acquisition Corp | COM CL A | G0904B105 | $8.4K | 843,122 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $7.8K | 324,614 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $7.4K | 362,735 | 0.0% |
| Relmada Therapeutics Inc(RLMD)Put | PUT | 75955J402 | $7.4K | 200,000 | 0.0% |
| Kura Oncology Inc. Common Stock(KURA) | COM | 50127T109 | $7.3K | 536,500 | 0.0% |
| Mirati Therapeutics(MRTXEUR) | COM | 60468T105 | $7.3K | 104,800 | 0.0% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $6.3K | 180,000 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $5.8K | 27,500 | 0.0% |
| Jiya Acquisition Corp | COM CL A | 47760M102 | $5.6K | 562,500 | 0.0% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $5.5K | 597,026 | 0.0% |
| Sarepta Tehrapeutics Inc(SRPT) | COM | 803607100 | $4.6K | 41,500 | 0.0% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $4.0K | 520,000 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $3.4K | 284,500 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $3.0K | 290,000 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $2.8K | 243,250 | 0.0% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $2.4K | 303,396 | 0.0% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $2.1K | 350,702 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $2.0K | 85,000 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $1.8K | 154,500 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $1.8K | 220,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $1.5K | 153,639 | 0.0% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $1.3K | 669,158 | 0.0% |
| Merus BV | COM | N5749R100 | $1.2K | 59,000 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $1.2K | 192,500 | 0.0% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $1.1K | 419,145 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $669 | 140,000 | 0.0% |
| Horizon Therapeutics PLC | SHS | G46188101 | $248 | 4,000 | 0.0% |
| Esperion Therapeutic(ESPR) | COM | 29664W105 | $201 | 30,000 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $149 | 10,000 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $143 | 5,000 | 0.0% |
| Dice Therapeutics Inc | COM | 23345J104 | $136 | 6,700 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $108 | 5,000 | 0.0% |
| NGM Biopharmaceuticals Inc(NGMUSD) | COM | 62921N105 | $98 | 7,500 | 0.0% |
| Kinnate Biopharma Inc | COM | 49705R105 | $60 | 5,000 | 0.0% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $56 | 36,302 | 0.0% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/2027 | 67080N119 | $15 | 90,832 | 0.0% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $10 | 1,000 | 0.0% |